NY/NJ CEO
Date: Location: Cost:
November 13 - 14, 2018 Apella at Alexandria Center
450 E. 29 Street
New York, NY 10016
(212) 706-4100
Location >

Starting at $1950

 

Dress Code:
Business Attire

Register

NY/NJ CEO - PAST AGENDA 2017

2018 Steering Committee Members
Jennifer Hawks Bland, CEO, NewYorkBIO; Ron CohenPresident and CEO, Acorda Therapeutics Inc.; Chandra RamanathanHead East Coast Innovation Center Bayer US, Bayer;  Daniel TeperFounder and CEO, IMMUNE Pharmaceuticals; Jane WasmanPresident, International and General Counsel, Acorda Therapeutics Inc.; Susan Windham-BannisterPresident and CEO, Biomedical Growth Strategies LLC 

Time Agenda
8:00-9:00 am

Registration & Networking Breakfast

9:00-9:20 am

Welcome and Opening Remarks
Glenn Kazo, President, Prolong Pharmaceuticals; Ramesh KumarPresident & CEO, Onconova Therapeutics; Jonathan Peacock, Chairman, Arix Bioscience 

9:20-9:50 am

Plenary Session: Market Dynamics & Major Issues for BioPharma and Healthcare in 2018 & Beyond
Wei He
CEO, Founder & Inventor, Zhejiang DTRM BioPharma; Jonathan Lewis, Executive Chairman & CEO, Samus Therapeutics; Mani MohindruCFO & CSO, Cara Therapeutics; David WilsonCOO, Omnitura Therapeutics
Moderator: Ron Cohen, President & CEO, Acorda Therapeutics

9:50-10:20 am

State of the Markets: Biotech and Pharma
Scott Myers, CEO, President & Director, Cascadian Therapeutics; Gerard Soula, President & CEO, Adocia; Ron Squarer, CEO, Array BioPharma
Moderator: Robert Forrester, President & CEO, Verastem

10:20-10:50 am

Networking Break

10:50-11:30 am

Big Pharma & Biotech: Managing Risk in Early Stage Innovation
Michael Aberman, President & CEO, Quentis Therapeutics; Mark Benedyk, President & CEO, Telephus Biosciences; Carl Gordon, Partner, OrbiMed; Jonathan Peacock, Chairman, Arix Bioscience; Erika SmithCEO, ReNetX Bio; Robert Urban, Global Head, Johnson & Johnson Innovation
Moderator: David Barrow, Head of Life Sciences & Medtech for the Americas, Managing Director,  L.E.K. Consulting

11:30-12:00 pm

Alternative Financing Methods
Abid AnsariVP, Finance, Precision BioSciences;Constantine Chinoporos,CBO, Boston Pharmaceuticals; Uli Hacksell, Chairman of the Board, Cerecor; Pedro Lichtinger, Chairman & CEO, ChemioCare; Maria Maccecchini, President & CEO, QR Pharma
Moderator: Glenn KazoPresident, Prolong Pharmaceuticals 

12:00-1:15 pm

Networking Lunch

1:15-1:45 pm

Therapeutic Market Focus: Oncology & Immunotherapy
Steve Carchedi
, CEO, Apexian Pharmaceuticals; Jimmy Lin, CSO, Oncology, Natera; Matthew Price, EVP & COO, Phosplatin Therapeutics; Robert Stein, Senior Advisor, R&D, Agenus
Moderator: David Wilson,COO, Omnitura Therapeutics

1:45-2:15 pm

Accessing Innovation in Drug Discovery - Ensuring Transparency & Drug Value
Michael Foley, Sanders Director, Tri-Institutional Therapeutics Discovery Institute; Jonathan Lewis, Executive Chairman & CEO, Samus Therapeutics; Thomas Lonngren, Strategic Advisor, NDA Group; Samuel Waksal, Founder, MeiraGTx
Moderator: Ramesh KumarPresident & CEO, Onconova Therapeutics

2:15-2:45 pm

Networking Break

2:45-3:15 pm

Moderated Keynote
Ron Cohen, President & CEO, Acorda Therapeutics
Moderator: Samuel Waksal, Founder, MeiraGTx

3:15-4:00 pm

Partner or Go it Alone
Andrew Hindman, Chief Business Development Officer, Acorda Therapeutics; Mark Spizer, COO, Gusto Global; Moshe Weinstein, CEO, Moebius Medical 
Moderator: Mark Simon, Partner, Torreya Partners

4:00-5:00 pm

Cocktails & Hors d’oeuvres

NY/NJ CEO - NOVEMBER 14, 2018

2018 Steering Committee Members
Jennifer Hawks Bland, CEO, NewYorkBIO; Ron CohenPresident and CEO, Acorda Therapeutics Inc.; Chandra RamanathanHead East Coast Innovation Center Bayer US, Bayer;  Daniel TeperFounder and CEO, IMMUNE Pharmaceuticals; Jane WasmanPresident, International and General Counsel, Acorda Therapeutics Inc.; Susan Windham-BannisterPresident and CEO, Biomedical Growth Strategies LLC 

Time Agenda
8:30-9:30 am

Registration & Networking Breakfast

9:30-9:45 am

Welcome and Opening Remarks
Francois Nader, Chairman, Acceleron Pharma; John Nicols, President & CEO, Codexis; Bob Silverman, Head, Externalized Drug Discovery Partnering, Roche

9:45-10:15 am

Moderated Keynote: Emerging Areas of Unmet Needs
Mikael Dolsten
President, Worldwide R&D, Pfizer
Moderator: John Nicols, President & CEO, Codexis

10:15-10:45 am

The Path from Big Data to Precision Medicine
Aris Baras,
VP, Head of Genetics Center, Regeneron; Toby Bloom, Deputy Scientific Director, Informatics, New York Genome Center; Olivier Elemento, Director, Englander Institute for Precision MedicineIris PerlCEO, Prize4Life; David Shaywitz, CMO, DNAnexus
Moderator: Jeffrey ReidExecutive Director, Head of Genome InformaticsRegeneron

10:45-11:15 am

Networking Break

11:15-11:45 am

Therapeutic Market Focus: Impact on Industry in the Rare Disease and Microbiome Space
Colleen Cutcliffe, CEO & Co-Founder, Whole Biome; Anil Diwan, President & Chairman, NanoViricides; Mark Spizer, COO, Gusto Global
Moderator: Jeffrey Reid, Executive Director, Head of Genome Informatics, Regeneron 

11:45-12:15 pm

Moderated Keynote
Adena Friedman
, President & CEO, NASDAQ
Moderator: Steve Abrams, Partner Global Life Sciences Leadership TeamHogan Lovells

12:15-1:15 pm

Networking Lunch

1:15-1:45 pm

Maintaining Momentum: Innovative Deals & Partnerships
Elcin Ergun Barker, EVP, Head of New Businesses, Merck Group; Adam Golden, Partner, Head of NY Corporate Practice Group, Hogan Lovells;  Joseph Payne, President & CEO, Arcturus Therapeutics; Erika Smith, CEO, ReNetX Bio
Moderator: Bob Silverman, Head, Externalized Drug Discovery Partnering, Roche

1:45-2:15 pm

Global Markets: Biotechs Across Borders
Carl Firth, Founder & CEO, Aslan Pharmaceuticals; Francois Nader, Chairman, Acceleron Pharma; James Sapirstein, CEO, Contravir Pharmaceuticals
Moderator: Samuel Waksal, Founder, MeiraGTx

2:15-2:45 pm

Building a Biotech: Innovative Business Models
Robert Bratzler, Co-Founder & CEO, BioTrak Therapeutics; Robert Stein, Senior Advisor, R&D, Agenus
Moderator: Benjamin ZeskindCo-Founder & CEO, Immuneering Corporation

2:45-3:15 pm

Networking Break

3:15-3:45 pm

Moderated Keynote
George Yancopoulos, President & CSO, Regeneron
Moderator: Ron Cohen, President & CEO, Acorda Therapeutics

3:45-4:15 pm

Presentation of NY/NJ CEO Lifetime Achievement Award
Presented by: Ron Cohen, 2013 HonoreeFrancois Nader, 2016 HonoreeGeorge Yancopoulos, 2012 Honoree

4:15-5:15 pm

Cocktails & Hors d'oeuvres

Executive Sponsors: (see all sponsors)

<